Severe hypertension associated with the use of amphotericin B: An appraisal on the reported cases

Journal of Hypertension

Volumn 24, Issue 7, 2006, Pages 1445-

  Wiwanitkit, Viroj ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

DRUG EFFICACY; HUMAN; HYPERTENSION; LETTER; MYCOSIS; NEPHROTOXICITY; PRIORITY JOURNAL;

EID: 33745464581     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000234127.86390.54     Document Type: Letter

References (8)

1. Lemke A, Kiderlen AF, Kayser O, Amphotericin B. Appl Microbiol Biotechnol 2005; 68:151-162.
2. Rowles DM, Fraser SL. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review. Clin Infect Dis 1999; 29:1564-1565.
3. Ferreira E, Perreault MM. Hypertension exacerbated by amphotericin B administration. Ann Pharmacother 1997; 31:1407-1408.
4. Le Y, Rana KZ, Dudley MN. Amphotericin B-associated hypertension. Ann Pharmacother 1996; 30:765-767.
5. Omizo MK, Bryant RE, Loveless MO. Amphotericin B-induced malignant hypertension. Clin Infect Dis 1993; 17:817-818.
6. Katz BZ, Cohn RA. Amphotericin B and hypertension. Pediatr Infect Dis J 1994; 13:839-840.
7. Dukes CS, Perfect JR. Amphotericin B-induced malignant hypertensive episodes. J Infect Dis 1990; 161:588.
8. Rodrigues CA, Yamamoto M, Aranters AM, Chauffaille ML, Colombo AL, Bordin JO. Amphotericin B-induced severe hypertension in a young patient: a case report and a review of the literature. Ren Fail 2006; 28:185-187.